Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin

MLA

Zhenzhen Deng, et al. “Low Molecular Weight Fucoidan LF2 Improves the Immunosuppressive Tumor Microenvironment and Enhances the Anti-Pancreatic Cancer Activity of Oxaliplatin.” Biomedicine & Pharmacotherapy, vol. 173, no. 116360-, Apr. 2024. EBSCOhost, https://doi.org/10.1016/j.biopha.2024.116360.

APA

Zhenzhen Deng, Suo Qishan, Quanbin Zhang, Jing Wang, Yang Yue, Lihua Geng, & Ning Wu. (2024). Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin. Biomedicine & Pharmacotherapy, 173(116360-). https://doi.org/10.1016/j.biopha.2024.116360

Chicago

Zhenzhen Deng, Suo Qishan, Quanbin Zhang, Jing Wang, Yang Yue, Lihua Geng, and Ning Wu. 2024. “Low Molecular Weight Fucoidan LF2 Improves the Immunosuppressive Tumor Microenvironment and Enhances the Anti-Pancreatic Cancer Activity of Oxaliplatin.” Biomedicine & Pharmacotherapy 173 (116360-). doi:10.1016/j.biopha.2024.116360.